Brexpiprazole (Rexulti) Pharmacology Podcast

Podcast: Play in new window | Download (Duration: 15:08 — 6.9MB) | Embed

Subscribe: RSS | More

Brexpiprazole (Rexulti) is a second generation antipsychotic. I discuss its pharmacology, adverse effects, drug interactions, and more in this podcast episode.

I like to associate brexpiprazole with aripiprazole. They have a lot of overlapping characteristics, particularly in relation to the adverse effect profile.

Brexpiprazole tends to have a low incidence of metabolic adverse effects which makes it a nice selection for patients who have diabetes, hypercholesterolemia, or who are overweight.

CYP3A4 and CYP2D6 are the two primary enzymes that break down brexpiprazole. I discuss the pharmacogenomic considerations associated with this medication.

Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE!